Literature DB >> 25291964

Cardiac fibroblasts: contributory role in septic cardiac dysfunction.

Kengo Tomita1, Mitchinori Takashina1, Natsumi Mizuno1, Kimimasa Sakata1, Kohshi Hattori2, Joji Imura3, Wakana Ohashi1, Yuichi Hattori4.   

Abstract

BACKGROUND: Cardiac dysfunction is a frequent and severe complication of septic shock and contributes to the high mortality of sepsis. Although several mechanisms have been suspected to be responsible for sepsis-associated cardiac dysfunction, the precise cause(s) remains unclear to date.
MATERIALS AND METHODS: We tested the hypothesis that cardiac fibroblasts may play a critical role as a disease modifier involved in sepsis-associated cardiac dysfunction. Human cardiac fibroblasts (HCFs) cultured in vitro were exposed to lipopolysaccharide (LPS). Changes in cardiac morphology and function were assessed in mice with cecal ligation and puncture-induced sepsis.
RESULTS: In LPS-stimulated HCFs, messenger RNA and protein levels of proinflammatory molecules, including tumor necrosis factor-α, interleukin-1β, interleukin-6, and monocyte chemoattractant protein-1, were strikingly upregulated. LPS also increased expression and activity of matrix metalloproteinase (MMP)-9, but not MMP-2. LPS-induced expression of α-smooth muscle actin, a classical marker for myoblast differentiation, which was abrogated when MMP-9 small interfering RNA was transfected into HCFs. High gene expression levels of proinflammatory cytokines and MMP-9 were observed in the heart tissues of cecal ligation and puncture-induced septic mice. Histology sections of the hearts from septic mice showed perivascular and interstitial cardiac fibrosis, and echocardiography demonstrated that septic mice had profound cardiac dysfunction. The broad-spectrum MMP inhibitor ONO-4817 significantly alleviated these histologic and functional changes during the acute phase.
CONCLUSIONS: We suggest that cardiac fibroblasts are of pathogenetic importance in inflammation and fibrosis in the heart during sepsis, leading to cardiac dysfunction that would affect the outcome of sepsis syndrome.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac dysfunction; Cardiac fibroblast; Cardiac fibrosis; Inflammation; Polymicrobial sepsis

Mesh:

Substances:

Year:  2014        PMID: 25291964     DOI: 10.1016/j.jss.2014.09.012

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  14 in total

1.  Cardioprotective and functional effects of levosimendan and milrinone in mice with cecal ligation and puncture-induced sepsis.

Authors:  Shigeyuki Yamashita; Tokiko Suzuki; Keisuke Iguchi; Takuya Sakamoto; Kengo Tomita; Hiroki Yokoo; Mari Sakai; Hiroki Misawa; Kohshi Hattori; Toshi Nagata; Yasuhide Watanabe; Naoyuki Matsuda; Naoki Yoshimura; Yuichi Hattori
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-20       Impact factor: 3.000

Review 2.  [Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy].

Authors:  L Martin; M Derwall; C Thiemermann; T Schürholz
Journal:  Anaesthesist       Date:  2017-07       Impact factor: 1.041

3.  Tissue inflammation and nitric oxide-mediated alterations in cardiovascular function are major determinants of endotoxin-induced insulin resistance.

Authors:  Lawrence M House; Robert T Morris; Tammy M Barnes; Louise Lantier; Travis J Cyphert; Owen P McGuinness; Yolanda F Otero
Journal:  Cardiovasc Diabetol       Date:  2015-05-20       Impact factor: 9.951

Review 4.  Pathophysiology of sepsis-induced myocardial dysfunction.

Authors:  Xiuxiu Lv; Huadong Wang
Journal:  Mil Med Res       Date:  2016-09-27

5.  Correlations between ACE single nucleotide polymorphisms and prognosis of patients with septic shock.

Authors:  Xin-Man Dou; Hui-Juan Cheng; Ling Meng; Lin-Lin Zhou; Yi-Hong Ke; Li-Ping Liu; Yu-Min Li
Journal:  Biosci Rep       Date:  2017-04-28       Impact factor: 3.840

6.  Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis.

Authors:  Alan J Mouton; Yonggang Ma; Osvaldo J Rivera Gonzalez; Michael J Daseke; Elizabeth R Flynn; Tom C Freeman; Michael R Garrett; Kristine Y DeLeon-Pennell; Merry L Lindsey
Journal:  Basic Res Cardiol       Date:  2019-01-11       Impact factor: 17.165

7.  Cardiac Electrical and Structural Changes During Bacterial Infection: An Instructive Model to Study Cardiac Dysfunction in Sepsis.

Authors:  Michael A Makara; Ky V Hoang; Latha P Ganesan; Elliot D Crouser; John S Gunn; Joanne Turner; Larry S Schlesinger; Peter J Mohler; Murugesan V S Rajaram
Journal:  J Am Heart Assoc       Date:  2016-09-12       Impact factor: 5.501

8.  Critical role of endogenous histamine in promoting end-organ tissue injury in sepsis.

Authors:  Mizuki Hattori; Mitsuaki Yamazaki; Wakana Ohashi; Satoshi Tanaka; Kohshi Hattori; Kenichiro Todoroki; Toshio Fujimori; Hiroshi Ohtsu; Naoyuki Matsuda; Yuichi Hattori
Journal:  Intensive Care Med Exp       Date:  2016-11-08

9.  Systems Pharmacology Dissection of Traditional Chinese Medicine Wen-Dan Decoction for Treatment of Cardiovascular Diseases.

Authors:  Tao-Hua Lan; Lu-Lu Zhang; Yong-Hua Wang; Huan-Lin Wu; Dan-Ping Xu
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-10       Impact factor: 2.629

10.  Vascular endothelial growth factor contributes to lung vascular hyperpermeability in sepsis-associated acute lung injury.

Authors:  Kengo Tomita; Yuna Saito; Tokiko Suzuki; Samar Imbaby; Kohshi Hattori; Naoyuki Matsuda; Yuichi Hattori
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-07-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.